Total medical devices industry venture financing deals in November 2020 worth $717.85m were announced in the US, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked an increase of 3.2% over the previous month and a drop of 11.9% when compared with the last 12-month average of $815.09m.
The US held a 73.7% share of the global medical devices industry venture financing deal value that totalled $974.26m in November 2020.
In terms of deal activity, the US recorded 31 deals during November 2020, marking a decrease of 35.4% over the previous month and a drop of 45.6% over the 12-month average.
The US medical devices industry venture financing deals in November 2020: Top deals
The top five medical devices industry venture financing deals accounted for 55.03% of the overall value during November 2020.
The combined value of the top five medical devices venture financing deals stood at $395m, against the overall value of $717.85m recorded for the month.
The top five medical devices industry deals of November 2020 tracked by GlobalData were:
1) Hillhouse Capital Group, LYFE Capital, Orbimed Advisors and RA Capital Management’s $120m venture financing of Cytek Biosciences
2) The $100m venture financing of Carbon Health Medical Group by Brookfield Technology Partners II, Builders VC, DCVC Management Co and Dragoneer Investment Group
3) 3M Ventures, ARTIS Ventures, DigiTx Partners, Highland Capital Partners, NTT Venture Capital and Questa Capital Management’s $65m venture financing of Eko Devices
4) The $65m venture financing of AliveCor by Bold Capital Partners, Khosla Ventures, Omron Healthcare, Qualcomm Ventures and WP Global Partner
5) GL Ventures and Sinovation Ventures’ venture financing of Wallaby Medical for $45m.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.
